Filing Details
- Accession Number:
- 0001415889-25-000407
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-03 16:15:19
- Reporting Period:
- 2025-01-01
- Accepted Time:
- 2025-01-03 16:15:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1840233 | Xilio Therapeutics Inc. | XLO | Pharmaceutical Preparations (2834) | 851623397 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1988344 | James Christopher Frankenfield | 828 Winter Street, Suite 300 Waltham MA 02451 | Chief Financial Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-01 | 19,375 | $0.00 | 19,375 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-01-02 | 6,954 | $0.98 | 12,421 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2025-01-01 | 19,375 | $0.00 | 19,375 | $0.00 |
| Common Stock | Stock Option (right to buy) | Acquisiton | 2025-01-01 | 251,000 | $0.00 | 251,000 | $0.96 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 58,125 | No | 4 | M | Direct | ||
| 251,000 | 2035-12-31 | No | 4 | A | Direct |
Footnotes
- Restricted stock units ("RSUs) convert to stock on a one-for-one basis
- The reported sale of 6,954 shares occurred automatically in a "sell to cover" transaction pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 8, 2024 solely to cover tax withholding obligations in connection with the vesting of restricted stock units.
- These RSUs were granted on January 1, 2024 and will vest in four equal annual installments beginning on January 1, 2025 and continuing through January 1, 2028.
- The option was granted on January 1, 2025 and will vest in 48 equal monthly installments beginning on February 1, 2025 and continuing through January 1, 2029.
Billionaire Hedge Funds
